10/5/18 1
BATTLING THE MYTHS AND FEARS REGARDING PEDIATRIC VACCINES
RC Hellinga, Pharm.D., BCPPS UNMH Pediatric ICU Pharmacist 10/8/2018
Disclosures
- Nothing to disclose
BATTLING THE MYTHS AND FEARS REGARDING PEDIATRIC VACCINES RC - - PDF document
10/5/18 BATTLING THE MYTHS AND FEARS REGARDING PEDIATRIC VACCINES RC Hellinga, Pharm.D., BCPPS UNMH Pediatric ICU Pharmacist 10/8/2018 Disclosures Nothing to disclose 1 10/5/18 Pharmacist Objectives Describe 5 of the most common
10/5/18 1
RC Hellinga, Pharm.D., BCPPS UNMH Pediatric ICU Pharmacist 10/8/2018
10/5/18 2
vaccines
10/5/18 3
contraindications and unnecessary rules
parent’s concern regarding the safety and efficacy surrounding pediatric vaccines
10/5/18 4
10/5/18 5
References:
CDC.gov\vaccines Canada.ca\vaccines Nhs.uk\vaccines
10/5/18 6
McKee C. J Pediatr Pharmacol Ther. 2016.
10/5/18 7
McKee C. J Pediatr Pharmacol Ther. 2016.
1.
Vaccines, specifically MMR causes autism
2.
The administration of multiple vaccines can overload the immune system
3.
Better to space out the vaccines more than current recommendations
4.
Natural infection confers better immunity
5.
Ingredients in vaccines can cause harm
6.
Disease rates have dropped due to factors other than vaccines
7.
Mandatory vaccines violate civil rights
8.
Abortions are required to produce vaccines
9.
VAERs data prove vaccines are dangerous
10/5/18 8
MMR and Thimerosal
http://vaxxedthemovie.com/ https://www.bmj.com/content/342/bmj.c7452
Wessel L. Science. April 17.
10/5/18 9
Medical Council and announced that Wakefield was:
fraudulent
Wessel L. Science. April 17.
Sharma SR. Pharmacology and Therapeutics. 2018. Yates K. Paediatrics and Child Health. 2016.
10/5/18 10
Uno Y. Vaccine. 2015. Jain A. JAMA. 2015. Mrozek-Budzyn D. Pediatr Infect Dis J. 2010 Design Case-control Retrospective cohort Case-Control Population Matching age & sex of each case Child > 5 with an older sibling 96 cases ASD = 192 controls matched by year of birth, sex Exposure Vaccination history: MMR vaccine OR thimerosal MMR vaccine (0+ doses) after 1 year of age Vaccination: MMR or Measles Outcomes ASD ASD ASD diagnosis Results ORs for MMR/thimerosal
No significant difference Total N – 95,727 Kids w ASD sibling:
Kids w/o ASD sibling:
Before diagnosis (MMR): OR 0.17 95%CI 0.06-0.52 Before diagnosis (Measles): OR: 0.44 95%CI 0.22-0.91 Vaccinated vs nonvaccinated: OR: 0.28 95%CI 0.1-0.76 Conclusion MMR/Thimerosal ≠ ASD MMR ≠ ASD MMR/Measles ≠ ASD
Kennedy, Jr.
was removed
Wessel L. Science. April 17.
10/5/18 11
Kennedy, Jr.
fraud tainting the science behind the connection”
Wessel L. Science. April 17.
Wessel L. Science. April 17. Uno Y. Vaccine. 2015. CDC.gov. “Understanding Thimerosal, Mercury, and Vaccine Safety.” 2013.
10/5/18 12
Wessel L. Science. April 17.
10/5/18 13
Vaccine Education Center at Children’s Hospital of Philadelphia. Volume 4. Winter 2018. Offit PA. Pediatrics. 2002.
Offit PA. Pediatrics. 2002. Hviid A. JAMA. 2005 Karvonen M. BMJ. 1999. Griffin MR. N Engl J Med. 1988.
10/5/18 14
vaccine as it is for 2 vaccines
Cohn M. Immunol Rev. 1990.
CDC, AAP, AAFP. Hib Disease and the Vaccine (Shot) to Prevent It. April 2017.
Vaccine Education Center at Children’s Hospital of Philadelphia. Volume 4. Winter 2018.
10/5/18 15
Varicella Haemophilus infuenzae Type b Pneumococcus Rubella Hepatitis B Measles Outcome 1 SSTIs Loss of limbs Death Heart problems Cirrhosis Ear infections Outcome 2 Pneumonia Brain damage Hearing loss Hearing loss Hepatocellular Carcinoma Hearing loss Outcome 3 Encephalitis Hearing loss Developmental delay Eyesight loss Death Diarrhea Outcome 4 Bleeding problems Death Pericarditis Intellectual disability Pneumonia/ encephalitis Outcome 5 Sepsis Empyema Liver damage Death Outcome 6 Death Endobronchial
Spleen damage Premature/LBW newborns
https://www.cdc.gov/chickenpox/about/complications.html https://www.cdc.gov/hi-disease/about/diagnosis-treatment.html https://www.cdc.gov/pneumococcal/about/symptoms-complications.html https://www.cdc.gov/rubella/about/complications.html https://www.cdc.gov/measles/about/complications.html Ormeci N. Fundam Clin Pharmacol. 2003.
10/5/18 16
Thompson AE. JAMA. April 2015.
Vaccine Components: Proteins/Sugars
better immunity
multiple doses
response waning
Otto S. J Infect. 2000. https://www.chop.edu/centers-programs/vaccine-education-center/vaccine-safety/immune-system-and-health
10/5/18 17
Haemophilus influenzae type b capsular polysaccharide
Natural Haemophilus type B capsular polysaccharide (PRP) PRP-diphtheria PRP-group B Neisseria meningitis Haemophilus type B
Total patients
24 17 22 24 20
Mean Titer
0.97 0.86 1.43 5.86 16.64
Jelonek MT. Infection and Immunity. Dec 1993. https://www.chop.edu/centers-programs/vaccine-education-center/vaccine-safety/immune-system-and-health
10/5/18 18
CDC.gov. “Ingredients of Vaccines – Fact Sheet.” July 2018. FDA.gov. “Common Ingredients in US Licensed Vaccines. April 2018.
10/5/18 19
10/5/18 20
Phadke VK. JAMA. 2016.
10/5/18 21
Sources: McLean HQ. MMWR. Prevention of Measles, Rubella, Congenital Rubella Syndrome, and Mumps, 2013: Summary Recommendations of the Advisroy committee on Immunization Practices. June 2013; 62(RR04);1-34. Measles data provided were reported voluntarily to CDC from state health departments.
Source: 1980–1997: National Bacterial Meningitis Reporting System and National Notifiable Diseases Surveillance (NNDSS) data; Adams WG, Deaver KA, Cochi SL, et al. Decline of childhood Haemophilus influenzae Type b (Hib) disease in the Hib vaccine era. JAMA 1993;269:221–6; CDC. Progress toward elimination of Haemophilus influenzae type b disease among infants and children—United States, 1987–1995. MMWR 1996;45:901–6; CDC. Progress toward elimination of Haemophilus influenzae type b disease among infants and children—United States, 1987–1997. MMWR 1998;47:993–8. 1998–2009: NNDSS and Active Bacterial Core Surveillance (ABCs) data. 2010–2012: ABCs cases estimated to the U.S. population.
10/5/18 22
CDC.gov. “What Would Happen If We Stopped Vaccinations.” June 2018.
10/5/18 23
reaction (anaphylaxis) after a previous dose or to a vaccine component
acute illness w/ or w/o fever
Clayton EW. Institute of Medicine. August 2011.
10/5/18 24
effect pairs
Clayton EW. Institute of Medicine. August 2011.
3.59-149.3)
association with the rotavirus vaccine and intussusception; 1.1-1.5 per 100,00 w/ RotaTeq and 5.1 per 100,000 with Rotarix
Maglione MA. Pediatrics. 2014.
10/5/18 25
Khakoo GA. BMJ. 2000. CDC.gov. “Flu vaccine and People with Egg Allergies.” December 2017.
10/5/18 26
today to establish care at your facility. The family contains the mother, father, and 2 children. The oldest child is going to start school this upcoming year. The youngest child was born 4 months ago. As the pharmacist for the clinic, you talk to the family to determine what has been done previously for both children.
received any vaccinations.
mom regarding vaccines?
10/5/18 27
state the truth regarding the purpose for these ingredients
She tells you her pediatrician stated that it is required for her child, who is now 15 months old, to receive the MMR vaccine.
mentions that she googled information regarding the MMR vaccine. She shows you information stating the MMR vaccine causes autism.
vaccine and autism?
10/5/18 28
10/5/18 29
the rounding pharmacist, you determine that this infant was not vaccinated
month vaccines may cause harm.
approach this family?
10/5/18 30
actually exposed
Take home: Education and taking time with the family has shown modest improvements regarding attitude towards vaccines
McKee C. J Pediatr Pharmacol Ther. 2016.
10/5/18 31
countries
10/5/18 32
RC Hellinga, Pharm.D., BCPPS UNMH Pediatric ICU Pharmacist 10/8/2018